Suvi Turunen1, Marja Vääräsmäki1, Tuija Männistö2, Anna-Liisa Hartikainen1, Anna-Maria Lahesmaa-Korpinen3, Mika Gissler3,4, Eila Suvanto1. 1. 1 Department of Obstetrics and Gynecology, PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu and University Hospital of Oulu, Oulu, Finland. 2. 2 Northern Finland Laboratory Centre Nordlab, Oulu, Finland. 3. 3 National Institute of Health and Welfare, Information Services Department, Helsinki, Finland. 4. 4 Karolinska Institute, Department of Neurobiology, Care Sciences and Society, Stockholm, Sweden.
Abstract
BACKGROUND: Maternal hypothyroidism has been associated with adverse pregnancy outcomes. A large nationwide register-based cohort with data on medication purchases was established to study the associations between maternal hypothyroidism, levothyroxine (LT4) use, and pregnancy and perinatal complications. METHODS: The data included all singleton births between 2004 and 2013 (N = 571,785) in Finland. Hypothyroid mothers (n = 16,364) were identified in the Finnish Medical Birth Register. Of these women, 95.8% used LT4 medication, and 37.5% had consistent LT4 use during pregnancy. Hypothyroid mothers were compared to mothers without thyroid disease (N = 550,860) using logistic regression. The main outcome measures were pregnancy and perinatal complications. RESULTS: Maternal hypothyroidism was associated with several pregnancy and perinatal complications, including gestational diabetes mellitus (odds ratio [OR] = 1.19 [confidence interval (CI) 1.13-1.25]), gestational hypertension (OR = 1.20 [CI 1.10-1.30]), severe preeclampsia (OR = 1.38 [CI 1.15-1.65]), cesarean section (OR = 1.22 [CI 1.17-1.27]), preterm births (OR = 1.25 [CI 1.16-1.34]), large-for-gestational age newborns (OR = 1.30 [CI 1.19-1.42]), major congenital anomalies (OR = 1.14 [CI 1.06-1.22]), and neonatal intensive care unit admission (OR = 1.23 [CI 1.17-1.29]). However, among mothers with consistent LT4 purchases, only the associations between gestational diabetes mellitus (OR = 1.12 [CI 1.03-1.22]), cesarean section (OR = 1.13 [CI 1.06-1.21]), neonatal intensive care unit admission (OR = 1.09 [CI 1.01-1.29]), and large-for-gestational age newborns (OR = 1.26 [CI 1.10-1.45]) and maternal hypothyroidism remained. CONCLUSIONS: Maternal hypothyroidism is associated with several pregnancy and perinatal complications, but consistent LT4 use may reduce many of the risks.
BACKGROUND:Maternal hypothyroidism has been associated with adverse pregnancy outcomes. A large nationwide register-based cohort with data on medication purchases was established to study the associations between maternal hypothyroidism, levothyroxine (LT4) use, and pregnancy and perinatal complications. METHODS: The data included all singleton births between 2004 and 2013 (N = 571,785) in Finland. Hypothyroid mothers (n = 16,364) were identified in the Finnish Medical Birth Register. Of these women, 95.8% used LT4 medication, and 37.5% had consistent LT4 use during pregnancy. Hypothyroid mothers were compared to mothers without thyroid disease (N = 550,860) using logistic regression. The main outcome measures were pregnancy and perinatal complications. RESULTS:Maternal hypothyroidism was associated with several pregnancy and perinatal complications, including gestational diabetes mellitus (odds ratio [OR] = 1.19 [confidence interval (CI) 1.13-1.25]), gestational hypertension (OR = 1.20 [CI 1.10-1.30]), severe preeclampsia (OR = 1.38 [CI 1.15-1.65]), cesarean section (OR = 1.22 [CI 1.17-1.27]), preterm births (OR = 1.25 [CI 1.16-1.34]), large-for-gestational age newborns (OR = 1.30 [CI 1.19-1.42]), major congenital anomalies (OR = 1.14 [CI 1.06-1.22]), and neonatal intensive care unit admission (OR = 1.23 [CI 1.17-1.29]). However, among mothers with consistent LT4 purchases, only the associations between gestational diabetes mellitus (OR = 1.12 [CI 1.03-1.22]), cesarean section (OR = 1.13 [CI 1.06-1.21]), neonatal intensive care unit admission (OR = 1.09 [CI 1.01-1.29]), and large-for-gestational age newborns (OR = 1.26 [CI 1.10-1.45]) and maternal hypothyroidism remained. CONCLUSIONS:Maternal hypothyroidism is associated with several pregnancy and perinatal complications, but consistent LT4 use may reduce many of the risks.
Authors: Isabelle Runkle; María Paz de Miguel; Ana Barabash; Martin Cuesta; Ángel Diaz; Alejandra Duran; Cristina Familiar; Nuria García de la Torre; Miguel Ángel Herraiz; Nuria Izquierdo; Ángel Diaz; Clara Marcuello; Pilar Matia; Verónica Melero; Carmen Montañez; Inmaculada Moraga; Natalia Perez-Ferre; Noelia Perez; Carla Assaf-Balut; Miguel Ángel Rubio; Jorge Gabriel Ruiz-Sanchez; Concepción Sanabria; María José Torrejon; Johanna Valerio; Laura Del Valle; Alfonso Calle-Pascual Journal: Front Endocrinol (Lausanne) Date: 2021-10-19 Impact factor: 5.555
Authors: Andréa Harumy de Lima Hirata; Luiz Antônio de Jesus Rocha; Valdelena Alessandra da Silva; Robson José de Almeida; Lucas Dos Santos Bacigalupo; Patrícia Varela; Leonardo Martins; João Bosco Pesquero; Humberto Dellê; Cleber Pinto Camacho Journal: Sci Rep Date: 2020-04-15 Impact factor: 4.379